Evidence map›Paper›PMID 32894089›Full record

ArticleBMC neurology2020

A rare case of anti-LGI1 limbic encephalitis with concomitant positive NMDAR antibodies.

Tuo Ji, Zhi Huang, Yajun Lian, Chengze Wang, Qiaoman Zhang, Jinghong Li

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Efgartigimod treatment for therapy-refractory autoimmune encephalitis with coexistent NMDAR and LGI1 antibodies: a case report and literature review.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Tuo JiDepartment of neurology, First Affiliated Hospital of Zhengzhou University, Zhengzhou City, 450052, Henan Province, China.
Zhi HuangDepartment of neurology, First Affiliated Hospital of Zhengzhou University, Zhengzhou City, 450052, Henan Province, China.
Yajun LianDepartment of neurology, First Affiliated Hospital of Zhengzhou University, Zhengzhou City, 450052, Henan Province, China. lianyajun369@yeah.net.ORCID http://orcid.org/0000-0002-0422-9078
Chengze WangDepartment of neurology, First Affiliated Hospital of Zhengzhou University, Zhengzhou City, 450052, Henan Province, China.
Qiaoman ZhangDepartment of neurology, First Affiliated Hospital of Zhengzhou University, Zhengzhou City, 450052, Henan Province, China.
Jinghong LiDepartment of neurology, First Affiliated Hospital of Zhengzhou University, Zhengzhou City, 450052, Henan Province, China.
First Affiliated Hospital of Zhengzhou University · CN

Funding

National Natural Science Foundation of China 81771397
6 · The paper itself

Abstract

backgroundN-methyl-D-aspartate receptor (NMDAR) and leucine-rich glioma-inactivated 1 (LGI1) antibodies define the most prevalently recognized autoimmune encephalitis syndromes, while the simultaneous occurrence of both conditions has hardly been published before. CASE PRESENTATION: We report the case of a 67-year-old patient who presented with generalized tonic-clonic seizures (GTCS) followed by behavioral changes, psychosis, sleep disorders, decreased consciousness, and faciobrachial dystonic seizures. Ancillary findings included serum hyponatremia and imaging evidence of high-intensity lesions within bilateral medial temporal lobes on T2-weighted fluid attenuation inversion recovery. Both LGI1 and NMDAR antibodies were positive in serum and cerebral spinal fluid using transfected cell based assays. Despite prominent clinical features of anti-LGI1 limbic encephalitis (LGI1-LE), the patient also exhibited overlapping symptoms of anti-NMDAR encephalitis, like early-onset GTCS, which might be related to the concomitant positive NMDAR antibodies.

conclusionsWe report a rare case of LGI1-LE with overlapping symptoms and simultaneous positive NMDAR antibodies. It is necessary to evaluate the presence of NMDAR antibodies in certain LGI1-LE patients with unusual symptoms. However, caution should be exercised in interpreting the observation, given the fact of a single-case study.

Indexed as

AgedAnti-N-Methyl-D-Aspartate Receptor EncephalitisAutoantibodiesEncephalitisHashimoto DiseaseHumansHyponatremiaIntracellular Signaling Peptides and ProteinsLimbic EncephalitisMagnetic Resonance ImagingMaleReceptors, N-Methyl-D-AspartateSeizuresAutoantibodiesIntracellular Signaling Peptides and ProteinsLGI1 protein, humanReceptors, N-Methyl-D-AspartateAntibodyAnti-leucine-rich glioma-inactivated 1Limbic encephalitisN-methyl-D-aspartate receptor

Identifiers

PMID32894089
PMCPMC7487823
OpenAlexW3083687143

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.